In-vivo and in-silico studies revealed the molecular mechanisms of Colocasia esculenta phenolics as novel chemotherapy against benign prostatic hyperplasia via inhibition of 5α-reductase and α1-adrenoceptor.
- Tusubira D et al (2023).
- In Silico Pharmacol.
- PubMed:
- 36873908